• Home
  • About Us
    • Company
    • Licenses and Patents
      • Licenses
      • Patents & Trademark
  • Product
    • TY-102 series
    • TY-101 series
    • KP-B210
    • KP-B220
  • Application
    • Vascular Access of HD
    • FAQ
    • PAOD
    • Wound
  • Global-Network
    • Distribution Network
    • Hospital Customers
  • Scientific Evidences
    • HD Vascular Access
    • PAOD
    • Chronic Wound
    • Peritoneal Dialysis
    • Mechanism & Non-thermal Effect
  • Contact

Get in touch

+886 2 82192005

info@firapy.com

logo
  • Home
  • About Us
    • Company
    • Licenses and Patents
      • Licenses
      • Patents & Trademark
  • Product
    • TY-102 series
    • TY-101 series
    • KP-B210
    • KP-B220
  • Application
    • Vascular Access of HD
    • FAQ
    • PAOD
    • Wound
  • Global-Network
    • Distribution Network
    • Hospital Customers
  • Scientific Evidences
    • HD Vascular Access
    • PAOD
    • Chronic Wound
    • Peritoneal Dialysis
    • Mechanism & Non-thermal Effect
  • Contact

Peritoneal Dialysis


FIR improves cardiovascular and infectious outcomes inPD patients

Far-infrared therapy improves cardiovascular and infectious outcomes in peritoneal dialysis patients

July 2, 2025
Abstract
FIR Improve Peritoneal Function and Reduce Peritonitis

Does Far-Infrared Therapy Improve Peritoneal Function and Reduce Recurrent Peritonitis in Peritoneal Dialysis Patients?

July 1, 2022
Abstract
FIR on the Peritoneal Membrane function of PD patients

The Effect of Far-Infrared Therapy on the Peritoneal Membrane Transport Characteristics of Uremic Patients Undergoing Peritoneal Dialysis: An Open-Prospective Proof-of-Concept Study

October 8, 2021
Abstract
The Effect of FIR on the Peritoneal Expression of GDPs in DM/PD patients

The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis

July 1, 2021
Abstract
Double-Pokemon-Ball Sign in EPS Responsive to FIR

Double-Pokemon-Ball Sign in Encapsulating Peritoneal Sclerosis Responsive to Far-Infrared Therapy

June 27, 2021
Abstract
FIR as a Novel Treatment for Encapsulating Peritoneal Sclerosis

Far-infrared Therapy as a Novel Treatment for Encapsulating Peritoneal Sclerosis

July 1, 2015
Letters to the Editor

WS Far IR Medical Technology

Office Address

2F, No.16, Lane 130, Minquan Rd., Xindian Dist, New Taipei City 231, Taiwan

TEL:+886-2-82192005

FAX:+886-2-82192009

E-MAIL:info@firapy.com

Application

Vascular Access

PAOD

Wound

Globa Network

Distuibutor

Hospital Customers

Cooperation Partners

© 2025 

All Rights Reserved |  WS FAR IR MEDICAL TECHNOLOGY CO., LTD


Share by: